Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Walzl

Showing results (31-40 of 283) with videos related to

Pageof 29
Sort By:
Tuberculosis (Edinburgh, Scotland)|December 9, 2022
Differences in biomarker concentrations in serum and urine of patients with Ocular Tuberculosis - A prospective descriptive studyFredrich J van der Colff, Candice Snyders, Gerhard Walzl, et al.
The Journal of Experimental Medicine|October 22, 2003
A critical role for OX40 in T cell-mediated immunopathology during lung viral infectionIan R Humphreys, Gerhard Walzl, Lorna Edwards, et al.
Immunity, Inflammation and Disease|March 3, 2017
B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatmentIlana C van Rensburg, Léanie Kleynhans, Alana Keyser, et al.
BMC Pulmonary Medicine|May 19, 2009
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary reportNovel N Chegou, Gillian F Black, Martin Kidd, et al.
The Journal of Infection|November 27, 2012
Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infectionAdane Mihret, Yonas Bekele, Kidest Bobosha, et al.
Tuberculosis (Edinburgh, Scotland)|November 6, 2007
High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controlsHanne Veenstra, Ralf Baumann, Pauline T Lukey, et al.
Cellular and Molecular Life Sciences : CMLS|November 16, 2019
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?Osagie A Eribo, Nelita du Plessis, Mumin Ozturk, et al.
ACS Infectious Diseases|May 27, 2021
Chronological Metabolic Response to Intensive Phase TB Therapy in Patients with Cured and Failed Treatment OutcomesMonique Opperman, Du Toit Loots, Mari van Reenen, et al.
Frontiers in Immunology|December 19, 2019
Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor CellsVini John, Leigh A Kotze, Eliana Ribechini, et al.
Cold Spring Harbor Perspectives in Medicine|December 6, 2014
Clinical immunology and multiplex biomarkers of human tuberculosisGerhard Walzl, Mariëlle C Haks, Simone A Joosten, et al.
Pageof 29

Showing results (31-40 of 283) with videos related to

Sort By:
Pageof 29
Tuberculosis (Edinburgh, Scotland)|December 9, 2022
Differences in biomarker concentrations in serum and urine of patients with Ocular Tuberculosis - A prospective descriptive studyFredrich J van der Colff, Candice Snyders, Gerhard Walzl, et al.
The Journal of Experimental Medicine|October 22, 2003
A critical role for OX40 in T cell-mediated immunopathology during lung viral infectionIan R Humphreys, Gerhard Walzl, Lorna Edwards, et al.
Immunity, Inflammation and Disease|March 3, 2017
B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatmentIlana C van Rensburg, Léanie Kleynhans, Alana Keyser, et al.
BMC Pulmonary Medicine|May 19, 2009
Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary reportNovel N Chegou, Gillian F Black, Martin Kidd, et al.
The Journal of Infection|November 27, 2012
Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infectionAdane Mihret, Yonas Bekele, Kidest Bobosha, et al.
Tuberculosis (Edinburgh, Scotland)|November 6, 2007
High levels of intracellular IL-4 are expressed in circulating apoptotic T cells in patients with tuberculosis and in community controlsHanne Veenstra, Ralf Baumann, Pauline T Lukey, et al.
Cellular and Molecular Life Sciences : CMLS|November 16, 2019
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?Osagie A Eribo, Nelita du Plessis, Mumin Ozturk, et al.
ACS Infectious Diseases|May 27, 2021
Chronological Metabolic Response to Intensive Phase TB Therapy in Patients with Cured and Failed Treatment OutcomesMonique Opperman, Du Toit Loots, Mari van Reenen, et al.
Frontiers in Immunology|December 19, 2019
Caveolin-1 Controls Vesicular TLR2 Expression, p38 Signaling and T Cell Suppression in BCG Infected Murine Monocytic Myeloid-Derived Suppressor CellsVini John, Leigh A Kotze, Eliana Ribechini, et al.
Cold Spring Harbor Perspectives in Medicine|December 6, 2014
Clinical immunology and multiplex biomarkers of human tuberculosisGerhard Walzl, Mariëlle C Haks, Simone A Joosten, et al.
Pageof 29